OA10204A - Squalene synthetase inhibitors - Google Patents
Squalene synthetase inhibitors Download PDFInfo
- Publication number
- OA10204A OA10204A OA60759A OA60759A OA10204A OA 10204 A OA10204 A OA 10204A OA 60759 A OA60759 A OA 60759A OA 60759 A OA60759 A OA 60759A OA 10204 A OA10204 A OA 10204A
- Authority
- OA
- OAPI
- Prior art keywords
- neopentyl
- compound
- oxo
- chloro
- trans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36271394A | 1994-12-23 | 1994-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10204A true OA10204A (en) | 1996-12-18 |
Family
ID=23427229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA60759A OA10204A (en) | 1994-12-23 | 1995-12-22 | Squalene synthetase inhibitors |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5770594A (no) |
| JP (1) | JPH10500702A (no) |
| KR (1) | KR960022510A (no) |
| CN (1) | CN1133287A (no) |
| AU (1) | AU4067795A (no) |
| BG (1) | BG100248A (no) |
| BR (1) | BR9505995A (no) |
| CA (1) | CA2207772A1 (no) |
| CZ (1) | CZ344795A3 (no) |
| FI (1) | FI972696A (no) |
| GT (1) | GT199500058A (no) |
| HU (1) | HUT74672A (no) |
| IL (1) | IL116399A0 (no) |
| IS (1) | IS4312A (no) |
| LV (1) | LV11325B (no) |
| MA (1) | MA23746A1 (no) |
| MX (1) | MX9704683A (no) |
| NO (1) | NO955288L (no) |
| OA (1) | OA10204A (no) |
| PE (1) | PE60096A1 (no) |
| PL (1) | PL311997A1 (no) |
| SI (1) | SI9500393A (no) |
| SK (1) | SK158795A3 (no) |
| TN (1) | TNSN95133A1 (no) |
| TR (1) | TR199501644A2 (no) |
| WO (1) | WO1996020184A1 (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2401697A (en) * | 1996-06-20 | 1998-01-07 | Pfizer Inc. | 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors |
| US5965553A (en) * | 1996-06-20 | 1999-10-12 | Pfizer Inc. | Squalene synthetase inhibitors |
| DE19716120A1 (de) * | 1997-04-17 | 1998-10-22 | Europ Lab Molekularbiolog | Verwendung von cholesterinsenkenden Mitteln |
| US8679534B2 (en) * | 1997-12-12 | 2014-03-25 | Andrx Labs, Llc | HMG-CoA reductase inhibitor extended release formulation |
| US6403576B1 (en) * | 1998-08-24 | 2002-06-11 | The United States Of America As Represented By The Secretary Of The Navy | Antifungal and antiparasitic compounds |
| US20020054871A1 (en) * | 1999-04-12 | 2002-05-09 | Yadong Huang | Methods and compositions for use in the treatment of hyperlipidemia |
| EP1225880A2 (en) * | 1999-11-04 | 2002-07-31 | Andrx Corporation | Use of a hmg-coa reductase inhibitor for treating amyloid beta precursor disorders |
| US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
| WO2002042296A1 (en) * | 2000-11-21 | 2002-05-30 | Janssen Pharmaceutica N.V. | Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| WO2008121602A1 (en) * | 2007-03-29 | 2008-10-09 | Smithkline Beecham Corporation | Chemical compounds |
| GB0803747D0 (en) * | 2008-02-29 | 2008-04-09 | Martin | Enzyme and receptor modulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE235474T1 (de) * | 1992-04-20 | 2003-04-15 | Takeda Chemical Industries Ltd | 4,1-benzoxazepinderivate als squalen-synthetase inhibitoren und ihre verwendung zur behandlung von hypercholesterämie und als fungizide |
| AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
| WO1996009827A2 (en) * | 1994-09-20 | 1996-04-04 | Pfizer Inc. | Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
-
1995
- 1995-06-02 CA CA002207772A patent/CA2207772A1/en not_active Abandoned
- 1995-06-02 US US08/860,155 patent/US5770594A/en not_active Expired - Fee Related
- 1995-06-02 JP JP8520314A patent/JPH10500702A/ja active Pending
- 1995-06-02 WO PCT/IB1995/000424 patent/WO1996020184A1/en active Application Filing
- 1995-06-02 BR BR9505995A patent/BR9505995A/pt not_active Application Discontinuation
- 1995-06-02 SK SK1587-95A patent/SK158795A3/sk unknown
- 1995-06-02 MX MX9704683A patent/MX9704683A/es not_active IP Right Cessation
- 1995-12-13 GT GT199500058A patent/GT199500058A/es unknown
- 1995-12-14 IL IL11639995A patent/IL116399A0/xx unknown
- 1995-12-18 MA MA24097A patent/MA23746A1/fr unknown
- 1995-12-18 PE PE1995287390A patent/PE60096A1/es not_active Application Discontinuation
- 1995-12-19 IS IS4312A patent/IS4312A/is unknown
- 1995-12-21 BG BG100248A patent/BG100248A/xx unknown
- 1995-12-21 PL PL95311997A patent/PL311997A1/xx unknown
- 1995-12-21 TN TNTNSN95133A patent/TNSN95133A1/fr unknown
- 1995-12-21 LV LVP-95-379A patent/LV11325B/en unknown
- 1995-12-22 TR TR95/01644A patent/TR199501644A2/xx unknown
- 1995-12-22 OA OA60759A patent/OA10204A/en unknown
- 1995-12-22 CN CN95120143A patent/CN1133287A/zh active Pending
- 1995-12-22 CZ CZ953447A patent/CZ344795A3/cs unknown
- 1995-12-22 KR KR1019950054933A patent/KR960022510A/ko not_active Application Discontinuation
- 1995-12-22 NO NO955288A patent/NO955288L/no unknown
- 1995-12-22 AU AU40677/95A patent/AU4067795A/en not_active Abandoned
- 1995-12-22 HU HU9503783A patent/HUT74672A/hu unknown
- 1995-12-22 SI SI9500393A patent/SI9500393A/sl unknown
-
1997
- 1997-06-23 FI FI972696A patent/FI972696A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SI9500393A (en) | 1997-04-30 |
| IL116399A0 (en) | 1996-03-31 |
| FI972696A0 (fi) | 1997-06-23 |
| PL311997A1 (en) | 1996-06-24 |
| HUT74672A (en) | 1997-01-28 |
| GT199500058A (es) | 1997-06-05 |
| JPH10500702A (ja) | 1998-01-20 |
| TR199501644A2 (tr) | 1996-11-21 |
| TNSN95133A1 (fr) | 1996-02-06 |
| LV11325B (en) | 1997-02-20 |
| WO1996020184A1 (en) | 1996-07-04 |
| PE60096A1 (es) | 1996-12-28 |
| NO955288D0 (no) | 1995-12-22 |
| CN1133287A (zh) | 1996-10-16 |
| NO955288L (no) | 1996-06-24 |
| FI972696A (fi) | 1997-06-23 |
| IS4312A (is) | 1996-06-24 |
| US5770594A (en) | 1998-06-23 |
| HU9503783D0 (en) | 1996-04-29 |
| BG100248A (en) | 1996-07-31 |
| MX9704683A (es) | 1997-09-30 |
| KR960022510A (ko) | 1996-07-18 |
| CA2207772A1 (en) | 1996-07-04 |
| BR9505995A (pt) | 1997-12-23 |
| CZ344795A3 (en) | 1996-09-11 |
| MA23746A1 (fr) | 1996-07-01 |
| LV11325A (lv) | 1996-06-20 |
| AU4067795A (en) | 1996-07-04 |
| SK158795A3 (en) | 1997-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8101615B2 (en) | 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors | |
| CN1237055C (zh) | 三唑衍生物 | |
| CA2562075C (en) | Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators | |
| EP1438310B1 (en) | Beta-carbolin derivatives as ptp-inhibitors | |
| BRPI0806566A2 (pt) | Derivados de glicina n-substituída: inibidores de hidroxilase | |
| JP2009541351A (ja) | プロリルヒドロキシラーゼ阻害剤 | |
| US10085986B2 (en) | Pyrimidinone compounds and their use | |
| OA10204A (en) | Squalene synthetase inhibitors | |
| CA2208174A1 (en) | Squalene synthetase inhibitors | |
| EP1148053A1 (en) | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient | |
| CN1040755C (zh) | 杂环化合物的制备方法 | |
| US20110098324A1 (en) | Prolyl hydroxylase inhibitors | |
| SK8972002A3 (en) | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors | |
| WO2007026962A1 (ja) | フェニレン誘導体 | |
| JP4402176B2 (ja) | 新規アミド化合物及びこれを含有する医薬 | |
| JP2019507176A (ja) | Ｈｔｒａ１阻害剤としての新規ジフルオロケタミド誘導体 | |
| KR19990014070A (ko) | 파네실 전이효소 저해활성을 갖는 히단토인 유도체 | |
| EP3504197B1 (en) | New trifluoromethylpropanamide derivatives as htra1 inhibitors | |
| US6605604B1 (en) | Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them | |
| JP4647726B2 (ja) | 新規なアニリド化合物及びこれを含有する医薬 | |
| AU2011224417B2 (en) | 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (DPP-1) | |
| JPH11509857A (ja) | 心筋虚血治療用複素環式化合物 | |
| WO2012158399A1 (en) | Condensed 2 - carbamoylpyridazinones as potassium channel modulators | |
| CN116655540A (zh) | 一种Cat K抑制剂与制备方法及其应用 | |
| JPH06239859A (ja) | アンギオテンシンｉｉ拮抗作用を有する環状化合物およびその用途 |